Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach

BACKGROUND: Imiquimod (IMQ) is an immunomodulating drug that is approved for the treatment of superficial basal cell carcinoma, actinic keratosis, external genital warts and perianal warts. However, IMQ cream (Aldara(®)) has several drawbacks including poor skin permeation, local toxicity, and compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sangseo, Abdella, Sadikalmahdi, Abid, Fatima, Afinjuomo, Franklin, Youssef, Souha H, Holmes, Amy, Song, Yunmei, Vaidya, Sachin, Garg, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968428/
https://www.ncbi.nlm.nih.gov/pubmed/36855538
http://dx.doi.org/10.2147/IJN.S400610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968428/
https://www.ncbi.nlm.nih.gov/pubmed/36855538
http://dx.doi.org/10.2147/IJN.S400610

Ejemplares similares